Previous Article | Next Article 
Molecular and Cellular Biology, August 2000, p. 5447-5453, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Shared Roles of Yeast Glycogen Synthase Kinase 3 Family
Members in Nitrogen-Responsive Phosphorylation of Meiotic
Regulator Ume6p
Yang
Xiao and
Aaron P.
Mitchell*
Department of Microbiology and Institute of
Cancer Research, Columbia University, New York, New York 10032
Received 28 January 2000/Returned for modification 8 March
2000/Accepted 5 May 2000
 |
ABSTRACT |
Nitrogen limitation activates meiosis and meiotic gene expression
in yeast, but nitrogen-responsive signal transduction mechanisms that
govern meiotic gene expression are poorly understood. We show here that
Ume6p, a subunit of the Ume6p-Ime1p meiotic transcriptional activator,
undergoes increased phosphorylation in vivo in response to nitrogen
limitation. Phosphorylation depends on an N-terminal glycogen synthase
kinase 3 (GSK3) target site in which substitutions cause reduced
Ume6p-Ime1p interaction and meiotic gene expression, thus arguing that
phosphorylation promotes functional Ume6p-Ime1p interaction.
Phosphorylation of this site depends on two GSK3 homologs, Rim11p and
Mck1p. Prior studies indicate that Rim11p phosphorylates both Ume6p and
Ime1p in vitro and is required for Ume6p-Ime1p interaction, but no
evidence has linked Mck1p function to Ume6p activity. Here we find that
Mck1p-Ume6p interaction is detectable by two-hybrid assays and that
meiosis in a partially defective rim11-K68R mutant is
completely dependent on Mck1p. These findings argue that nitrogen
limitation governs Rim11p/Mck1p-dependent phosphorylation of Ume6p,
which in turn is required for Ume6p-Ime1p interaction and meiotic gene activation.
 |
INTRODUCTION |
The pathway of meiosis and spore
formation of the budding yeast Saccharomyces cerevisiae is
initiated in response to nitrogen limitation. Underlying this pathway
is a global change in gene expression: within 2 h after
starvation, 58 genes are activated over fivefold (8). Many
of these genes belong to the set of early meiotic genes, which are
required for normal progression through meiosis (20).
Expression of early meiotic genes depends on Ume6p and Ime1p, two
subunits of a heteromeric transcriptional activator. Ume6p-Ime1p
interaction is stimulated by nitrogen limitation (32), but
the mechanism through which nitrogen governs interaction is unknown.
Rim11p, a relative of glycogen synthase kinase 3 (GSK3), is required
for Ume6p-Ime1p interaction (25, 32). Rim11p phosphorylates both Ime1p and Ume6p in vitro within the interaction region of each
protein, and multisite amino acid substitutions that abolish phosphorylation in vitro also disrupt complex formation (4, 24,
25). Thus, regulation of Rim11p-dependent phosphorylation of
either substrate would provide a simple mechanism for regulation of
Ume6p-Ime1p complex formation. In vitro measurements indicate that
Rim11p specific activity is fourfold higher in acetate-grown cells than
in glucose-grown cells but have not revealed any response of Rim11p to
nitrogen limitation (25).
Rim11p is loosely related to Mck1p (44% identity), a second yeast GSK3
homolog that has diverse functions. Mck1p promotes growth at
temperature extremes, diauxic adaptation, centromere segregation, and
meiosis (6, 16, 27, 35). In meiosis, Mck1p has two known
roles (2, 27). First, it promotes IME1 transcription and is thus required indirectly for Ume6p-Ime1p interaction. Second, it promotes spore maturation, which occurs at the end of the meiotic program. Puziss et al. found that
overexpression of Rim11p improves growth of an mck1 mutant
at low and high temperatures (30), thus suggesting that
Rim11p and Mck1p might have partially overlapping functions. However,
mck1 mutant phenotypes are unaffected by a rim11
null mutation, and it has thus seemed equally likely that Rim11p
can substitute for Mck1p only when it is overexpressed.
In this study, we have examined the state of Ume6p phosphorylation in
vivo. Our findings indicate that Rim11p and Mck1p act together to
promote Ume6p phosphorylation and activity. The extent of Ume6p
phosphorylation depends on nutrient availability and on the nutritional
response protein kinase Rim15p (40), thus indicating that a
nutritional control pathway governs phosphorylation by Rim11p and
Mck1p. Our results predict a simple genetic interaction between
rim11 and mck1 mutations that may provide a
generally useful redundancy test for multifunctional protein kinases.
 |
MATERIALS AND METHODS |
Strains, genetic methods, and media.
S. cerevisiae
strains were derived from the SK-1 genetic background (19)
or from crosses between SK-1 strains and strain Y190 (10),
as indicated in Table 1. Several
mutations have been described previously, including
rim11::LEU2 (4), ime1
20 (36), PGAL1-IME1::TRP1
(38), ime2
4-lacZ (26),
ime2-7::HIS3::LEU2 (37), and
mck1
::TRP1 (27). The
mrk1
::URA3-Kl mutation as introduced by PCR
product-directed gene disruption using oligonucleotides MRK1.-60+kl.URA3 and MRK1.1860.3'+kl.URA3 (Table
2) and plasmid pWJ716 as a template for
the Kluyveromyces lactis URA3 gene (11); PCR with
outside primers MRK1.-104 and NotI-kl.URA3.1321-3' confirmed the
genotype. Strain construction involved standard methods including mating, meiotic crosses, and transformation (18).
Strains carrying
ume6 mutations were constructed as follows.
First, the
ume6
strain YX230 was constructed by PCR
product-directed
gene disruption (
1,
21) in strain AMP1488,
using oligonucleotides
UME6-up and UME6-dn (Table
2) and plasmid pRS314
as a
TRP1 template.
Trp
+ His
+
transformants (which express the
ime2-HIS3 fusion) were
purified
and tested in PCRs with oligonucleotides UME6.-100 and
pRS-marker-3'.
Other
ume6
strains resulted from crosses
between YX230 and strains
with relevant genotypes. To create strains
carrying different
ume6 point mutations, integrating
URA3-ume6 or
HIS3-ume6 plasmids
(described below)
were linearized within
URA3 (with
NcoI) or
HIS3 (with
PstI) and transformed into
ura3
ume6
or
his3 ume6
strains.
Yeast and bacterial media, including LB, YPD, YPAc, SC, and sporulation
medium, were prepared as described previously (
18,
38).
Plasmids. (i) UME6 derivatives.
Plasmid pKB186
carries the hemagglutinin epitope (HA)-tagged UME6-HA allele
(25). A 4-kb SpeI-HindIII fragment
from pKB186 containing UME6-HA was inserted into
SpeI-HindIII-digested vector pRS406 to
produce plasmid pYX148, an integrating UME6-HA plasmid. The
plasmid carrying untagged Ume6p, pYX147, was created by the same
strategy from plasmid pHY14-2 (5). UME6 plasmids with different point mutation were created by PCR-directed sequence alterations. To generate ume6-T99A (pYX285),
first-round PCR products were generated with plasmid pYX148 as template
and oligonucleotide UME6.-100 paired with UME6-T99A-3' and
oligonucleotide UME6-Asp718 paired with UME6-T99A. Two PCR products
were purified and used as template in the second-round PCR with
oligonucleotides UME6.-100 and UME6-Asp718. The resulting 0.9-kb DNA
fragment was purified, digested with SphI and
NheI, and inserted into
SphI-NheI-digested plasmid pYX147. An
analogous strategy was used to create ume6-T103 (pYX286), ume6-S107A (pYX287), and
ume6-Ala3 (pYX281). Presence of desired mutations and
absence of secondary mutations were confirmed by sequencing the entire
region that had been PCR amplified.
(ii) GBD and GAD fusions.
Fusions of the Gal4p DNA binding
domain (GBD) to full-length Rim11p and to Ime1p (residues 294 to 360)
have been described elsewhere (25).
To generate fusions of the Gal4 activation domain (GAD) to Ume6p
(residues 1 to 232), an
NcoI site was introduced at
UME6 codon 1 by PCR with oligonucleotides UME6-NcoI and
UME6-Asp718;
the templates were wild-type or mutant
UME6
plasmids. The purified
PCR products were digested with
Asp718, filled in with Klenow
polymerase, then
digested with
NcoI, and inserted into
NcoI-
SmaI-digested
vector pACTII. Each insert
was sequenced to confirm fidelity of
the PCR. The resulting GAD-Ume6p
fusion plasmids were pYX294 (wild
type), pYX282 (Ala3), pYX288
(T99A), pYX289 (T103A), and pYX290
(S107A).
The GAD-Mck1p(1-375) fusion was constructed by introducing an
XmaI site at
MCK1 bp-1 through a PCR with
oligonucleotides SmaI-MCK1.1
and MCK1.1628-3', cloning the
PCR product into vector pGEM(T),
and then ligating the
XmaI-
XhoI-released insert into
XmaI-
XhoI-digested
vector
pACTII.
Two-hybrid interaction assays.
Strains AMP1562 and
Y190 (10) carrying GBD, GBD-Rim11p, or
GBD-Ime1p(294-360) were mated with strain AMP1563 or Y187
(10) carrying GAD or GAD-Ume6p(1-232), and diploids were
selected on SC-Trp-Leu plates. For assays, 24-h cultures in SC-Trp-Leu
medium were diluted 1/25 into YPAc or SC-Trp-Leu medium and
harvested after three doublings.
-Galactosidase assays were
conducted on permeabilized cells. Determinations were averages from
three independent transformants; the range was less than 20% of the
mean value.
Phosphatase treatment.
Whole-cell extracts were prepared as
described previously (25) in a mixture containing 20 mM
Tris-HCl (pH 7.4), 5% glycerol, 100 mM NaCl, 100 mM KCl, 1 mM EDTA,
0.05%
-mercaptoethanol and protease inhibitors
(phenylmethylsulfonyl fluoride [0.15 mg/ml], leupeptin [1 µg/ml],
aprotinin [1 µg/ml], and pepstatin [1 µg/ml]). Five milligrams
of total protein extract was bound to 5 µg of 12CA5 and 200 µl of
50% protein A-Sepharose beads (Sigma) during a 1-h incubation at
4°C. The beads were washed twice with extraction buffer,
washed once with phosphatase buffer (100 mM Tris-HCl [pH 9.6],
2 mM MgCl2, 0.1 mM ZnCl2, protease
inhibitors), and suspended in 60 µl of phosphatase buffer; 15-µl
aliquots of the suspension were mock treated (with buffer alone),
phosphatase treated (with 2 U of calf intestinal phosphatase), or
phosphatase treated in the presence of phosphatase inhibitors (5 mM
sodium fluoride, 5 mM sodium phosphate, 10 mM sodium pyrophosphate, 1 mM NaVO3, 5 mM EGTA, and 5 mM EDTA). After a 15-min
incubation at 37°C, the reaction mixtures were boiled for 5 min with
10 µl of 3× Laemmli buffer.
Immunoblot analysis.
Cells were harvested from mid-log phase
in YPD or YPAc or after transfer from YPAc to sporulation medium for
3 h. The cell pellets were suspended at 10 units of optical
density at 600 nm per ml of 3× Laemmli buffer and boiled for 5 min. We
found that preservation of phosphorylation states was best with 5%
sodium dodecyl sulfate (SDS) in the 3× Laemmli buffer. After
centrifugation, supernatants were transferred to fresh tubes and loaded
on SDS-polyacrylamide gels [6% for full-length Ume6p; 10% for
GAD-Ume6p(1-232)] for polyacrylamide gel electrophoresis (PAGE).
Protein transfer and detection with anti-HA monoclonal antibody 12CA5
(BabCo), goat anti-mouse antibody conjugated to peroxidase
(Boehringer), and enhanced chemiluminescence detection reagents
(Amersham) followed standard procedures (25).
 |
RESULTS |
Phosphorylation of Ume6p in vivo.
To determine whether
Ume6p is phosphorylated in vivo, we examined the electrophoretic
mobility of Ume6-HAp. We identified Ume6-HAp through anti-HA
immunoblots of UME6 and UME6-HA strains (Fig. 1A, lanes 1 to 3 and 4 to 6, respectively). Ume6-HAp migrated as a disperse protein, and its
apparent size was affected by growth conditions: it was 130 kDa in
glucose-grown cells (lane 4), 140 kDa in acetate-grown cells (lane 5),
and 150 kDa in nitrogen-limited cells (lane 6). Ume6-HAp mobility was
unaffected by cell type or IME1 expression (data not shown).
The apparent size of Ume6-HAp was reduced to 120 kDa by treatment with
phosphatase; absence of phosphatase or presence of phosphatase plus
inhibitors had no effect (Fig. 1B). These results indicate that Ume6p
is phosphorylated in vivo and that the extent of Ume6p phosphorylation
is elevated in response to acetate medium and nitrogen limitation.

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 1.
Phosphorylation of Ume6p in vivo. (A) Mobilities of
wild-type and mutant Ume6p derivatives. Strain YX423 carrying
integrated UME6 plasmids was grown in rich glucose medium
(D; lanes 1, 4, 7, 10, 13, 16, and 19), rich acetate medium (Ac; lanes
2, 5, 8, 11, 14, 17, and 20), or acetate medium lacking nitrogen
(sporulation medium [Sp]; lanes 3, 6, 9, 12, 15, 18, and 21).
Migration of Ume6-HAp on SDS-PAGE was visualized on an anti-HA
immunoblot. The UME6 plasmids specified Ume6p (lanes 1 to
3), wild-type Ume6-HAp (lanes 4 to 6), or mutant Ume6-HAp derivatives
with substitutions specified above each set of three lanes (lanes 7 to
21). (B) Phosphatase treatment of Ume6-HAp. Anti-HA immune
complexes were prepared from strain YX423 carrying a plasmid specifying
Ume6-HAp and grown in rich glucose medium (lanes 1 to 4), rich acetate
medium (lanes 5 to 8), or acetate medium lacking nitrogen (lanes 9 to
12). Migration of Ume6-HAp on SDS-PAGE was visualized on an anti-HA
immunoblot. Prior to SDS-PAGE, the immune complexes were untreated
(lanes 1, 5, and 9) or incubated at 37°C with no addition (lanes 2, 6, and 10), with phosphatase (lanes 3, 7, and 11), or with phosphatase
plus phosphatase inhibitors (lanes 4, 8, and 12). (C) Effect of GSK3
homolog defects on Ume6-HAp mobility. SDS-PAGE mobility of Ume6-HAp was
examined on an immunoblot of strains YX423 (wild type; lanes 1 to 3),
YX425 (rim11; lanes 4 to 6), YX426 (mck1; lanes 7 to 9), YX427 (mrk1; lanes 10 to 12), YX428 (rim11
mck1; lanes 13 to 15), YX429 (mck1 mrk1; lanes 16 to
18), YX431 (rim11 mrk1; lanes 19 to 21), and YX424
(rim11 mck1 mrk1; lanes 22 to 24). Growth conditions and
symbols are as in panel A. Sizes are indicated in kilodaltons.
|
|
To identify the region of Ume6p required for phosphorylation, we
compared electrophoretic mobilities of Ume6-HAp and Ume6-HA-Ala5p,
a
mutant derivative that fails to undergo phosphorylation by Rim11p
in
vitro (
25). Ume6-HAp was apparently larger than
Ume6-HA-Ala5p
in both acetate-grown cells and nitrogen-starved cells
(Fig.
1A,
lanes 4 to 6 and 7 to 9). The Ala5 substitution affects a
GSK3
consensus site that includes residues T99, T103, and S107, and
we
examined effects of alanine substitutions for these residues.
Each
single substitution and a triple substitution (Ala3) caused
a
substantial reduction in Ume6-HAp size in nitrogen-starved cells
and,
to some extent, in acetate-grown cells (Fig.
1A). These results
indicate that Ume6p residues T99, T103, and S107 are each required
for
full levels of phosphorylation promoted by acetate medium
and nitrogen
limitation.
We used a GAD-Ume6p fusion protein that includes the Ume6p N-terminal
region (NTR; residues 1 to 232) to confirm that this
region is
phosphorylated in vivo. GAD-Ume6p(1-232) migrated as
59-, 64-, and 68-kDa forms in glucose-grown cells (Fig.
2A, lane
1). The 68-kDa form accumulated
at greater levels in acetate-grown
and nitrogen-starved cells, and
a 74-kDa form was also detectable
in nitrogen-starved cells (Fig.
2A,
lanes 2 and 3). A GAD-Ume6p(1-232)
mutant derivative carrying the Ala3
triple substitution existed
primarily as 59- and 64-kDa forms under all
growth conditions
(Fig.
2B [lane 7 compared to lane 4] and data
not shown). Both
the 68- and 74-kDa forms of wild-type
GAD-Ume6p(1-232) were sensitive
to phosphatase (Fig.
2B, lane 5).
These results confirm that the
Ume6p NTR is subject to phosphorylation
in vivo, that phosphorylation
depends on serine and threonine residues
in the 99-107 interval,
and that Ume6p NTR phosphorylation is
stimulated by nitrogen limitation.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
Phosphorylation of the Ume6p NTR in vivo. (A) Effect of
GSK3 homolog defects on mobility of GAD-Ume6p(1-232). Strains carrying
a GAD-Ume6p(1-232) plasmid were grown under conditions described in
the legend to Fig. 1A, and migration of GAD-Ume6p(1-232) on SDS-PAGE
was visualized on an anti-HA immunoblot. The strains had defects in
Rim11p, Mck1p, or Mrk1p, as indicated at the top, and are specified in
the legend to Fig. 1C. (B) Phosphatase treatment of GAD-Ume6p(1-232).
Anti-HA immune complexes were prepared from wild-type strain AMP107
carrying plasmids specifying GAD (lanes 1 to 3), GAD-Ume6p(1 to 232)
(lanes 4 to 6), or GAD-Ume6-Ala3p(1-232) (lanes 7 to 9) after growth
in acetate medium lacking nitrogen and were visualized after SDS-PAGE
on an anti-HA immunoblot. Prior to SDS-PAGE, the samples were incubated
at 37°C with no addition (lanes 1, 4, and 7), with phosphatase (lanes
2, 5, and 8), or with phosphatase plus phosphatase inhibitors (lanes 3, 6, and 9). Sizes are indicated in kilodaltons.
|
|
Functional activity of Ume6p phosphorylation-negative mutants.
Ume6p functions as both a repressor and an activator. In vegetative
cells, it binds to Sin3p and Rpd3p to repress many genes, including
early meiotic genes (3, 17, 28, 39). In meiotic cells, it
binds to Ime1p to activate early meiotic genes (5, 25, 32).
To determine whether these functions are governed by NTR
phosphorylation, we assayed repression and activation of the meiotic
IME2 promoter in strains expressing wild-type and phosphorylation-defective Ume6p derivatives.
Repression assays were conducted with
ime2-HIS3 and
ime2-lacZ fusion genes in
ime1
strains.
The
ime1
mutation ensures that
Ume6p functions as a
repressor, not an activator, at the
IME2 promoter
(
3). The
ime2-HIS3 fusion conferred a
His
+ phenotype in the absence of Ume6p and a
His

phenotype in the presence of Ume6p (Table
3), representing derepressed
and
repressed states. Presence of each phosphorylation-defective
Ume6p
derivative also caused a His

phenotype.
ime2-lacZ expression measurements indicate that wild-type
and mutant Ume6p derivatives all caused 20- to 30-fold repression
(Table
3,
ime1
strain). Northern analysis also indicated
that
Ume6p and Ume6-Ala5p repress the nonmeiotic gene
INO1
equally
well (data not shown). Therefore, disruption of Ume6p NTR
phosphorylation
does not affect repression.
Activation assays were conducted with the
ime2-lacZ fusion.
We compared its expression in
PGAL1-IME1 strains
and
ime1
strains
to estimate the level of
Ime1p-dependent activation. In the absence
of Ume6p, Ime1p had
little effect on
ime2-lacZ expression (Table
3). With
wild-type Ume6p, presence of Ime1p caused a 60-fold
increase in
ime2-lacZ expression. This level of expression is
greater than that observed in the absence of Ume6p and thus
cannot
arise simply from relief of repression. With Ume6-Ala3p
and Ume6-T99Ap,
Ime1p had no effect on
ime2-lacZ
expression; with Ume6-T103Ap
and Ume6-S107Ap, Ime1p promoted 5- and
16-fold increases in
ime2-lacZ expression,
respectively. The defects were reflected qualitatively
in assays of
sporulation and Ume6p-Ime1p interaction (Table
3).
These results argue
that Ume6p NTR phosphorylation promotes Ime1p
interaction and
meiotic gene activation. In addition, the three
GSK3 site residues
differ in functional
importance.
Role of the yeast GSK3 family in phosphorylation.
Rim11p
immune complexes can phosphorylate the Ume6p NTR in vitro
(25). However, we found that a rim11 null
mutation had little effect on Ume6-HAp phosphorylation under any growth
condition (Fig. 1C, lanes 4 to 6 compared to lanes 1 to 3).
Therefore, Rim11p is not required for Ume6p phosphorylation in vivo.
One explanation for this observation is that other protein kinases
related to Rim11p promote Ume6p phosphorylation. The closest
Rim11p
relatives in
S. cerevisiae are Mck1p and Mrk1p (
4,
14,
27,
30,
35). Single
mck1 and
mrk1 mutations
had little effect
on Ume6-HAp phosphorylation (Fig.
1C, lanes 7 to 9 and 10 to 12),
as did a
rim11 mrk1 double mutation (Fig.
1C,
lanes 19 to 21).
Double
rim11 mck1 and
mck1 mrk1
mutations caused some reduction
in Ume6-HAp phosphorylation, and a
triple
rim11 mck1 mrk1 mutation
caused a severe defect in
Ume6-HAp phosphorylation (Fig.
1C, lanes
13 to 18 and 22 to 24). These
defects were particularly evident
in nitrogen-starved cells. Therefore,
Rim11p, Mck1p, and Mrk1p
each contribute to Ume6p phosphorylation in
vivo.
To determine the role of each protein kinase in Ume6p NTR
phosphorylation, we examined GAD-Ume6p(1-232) electrophoretic
mobility
in strains lacking the kinases. In mutants lacking any single
kinase, as in the wild-type strain, we observed elevated levels
of the
68-kDa phosphorylated GAD-Ume6p(1-232) form in nitrogen-starved
cells
(Fig.
2A, lanes 4 to 12). A similar pattern was observed
with most
double mutants (lanes 16 to 21), but a mutant lacking
both Rim11p and
Mck1p had low levels of the 68-kDa GAD-Ume6p(1-232)
form during
nitrogen limitation (lanes 13 to 15). A mutant
lacking
all three kinases resembled the mutant lacking
Rim11p and Mck1p
(lanes 22 to 24). These results argue that Rim11p and
Mck1p together
account for the bulk of Ume6p NTR phosphorylation in
nitrogen-limited
cells.
Interaction of Ume6p with Mck1p.
Rim11p and Mck1p may
phosphorylate the Ume6p NTR directly and may thus interact with
the Ume6p NTR. Rim11p-Ume6p NTR interaction is detectable through
two-hybrid assays (25), and so we used this approach to test
for Mck1p-Ume6p interaction. Mck1p-Ume6p NTR interaction was detectable
and above background levels in quantitative assays (Table
4) and on
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal)
plates (data not shown). No interaction was detected between Mck1p and
the Ime1p C-terminal region (residues 294 to 360), which does interact
with Rim11p (4, 24, 32). We also detected no interaction
between Mrk1p and the Ume6p NTR (data not shown). These results
indicate that both Rim11p and Mck1p are capable of direct or indirect
interaction with the Ume6p NTR.
Shared roles of Rim11p and Mck1p in meiosis.
Our findings
indicate that Rim11p and Mck1p are together responsible for Ume6p
NTR phosphorylation in nitrogen-limited cells and that this
phosphorylation is required for activation of meiotic genes and
sporulation. This model predicts that rim11 mck1 double mutants may have a more severe sporulation defect than either single
mutant. The assessment is complicated because rim11 null mutants are completely defective in sporulation, as expected from their
defect in Ime1p phosphorylation (4, 24). Therefore, we used
strains that express a partially defective Rim11p derivative, Rim11-K68Rp, with an ATP binding site alteration. Rim11-K68Rp causes
substantially reduced protein kinase activity in vitro, yet strains
that express Rim11-K68Rp are capable of efficient sporulation
(4). We reasoned that the low level of Rim11-K68Rp kinase
activity may be adequate for sporulation only because of the
contribution from other protein kinases to Ume6p phosphorylation. We
found that Rim11p and Rim11-K68Rp stimulated sporulation to similar
levels in strains that express Mck1p (Table
5, strains YX504 and YX502). However,
only Rim11p stimulated sporulation in the absence of Mck1p; Rim11-K68Rp
did not (strains YX503 and YX501). Sporulation was dependent on Rim11p
protein kinase activity in these assays, because the
kinase-inactive Rim11-K68Ap did not permit sporulation in any strain.
The third GSK3 homolog, Mrk1p, had little effect on sporulation with
any Rim11p derivative (strains YX502 and -501 compared to strains
YX504 and -503). Therefore, Mck1p can compensate for a reduction in
Rim11p activity to promote sporulation. These results support the idea
that Rim11p and Mck1p act interchangeably to promote sporulation.
Dependence of Ume6p phosphorylation on Rim15p.
Prior studies
indicate that Rim15p stimulates Ume6p-Ime1p interaction
(41). To determine whether Rim15p is required for Ume6p phosphorylation, we compared Ume6-HAp forms in wild-type and
rim15 mutant strains. The rim15 mutation caused a
reduction in accumulation of phosphorylated forms of both
Ume6-HAp and GAD-Ume6p(1-232) (Fig.
3). Therefore, Rim15p promotes
phosphorylation of the Ume6p NTR.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of a rim15 mutation on Ume6-HAp and
GAD-Ume6p mobility. SDS-PAGE mobility of Ume6-HAp (lanes 1 to 4) and
GAD-Ume6p(1-232) (lanes 5 to 8) expressed in strains AMP107
(RIM15; lanes 1, 2, 5, and 6) and AMP1631
(rim15 ; lanes 3, 4, 7, and 8) was visualized on an
immunoblot. Growth conditions and symbols are as for Fig. 1. Sizes are
indicated in kilodaltons.
|
|
 |
DISCUSSION |
Formation of the Ume6p-Ime1p complex is tightly regulated by
nitrogen limitation and by the protein kinase Rim11p (32). Here we have shown that these regulatory signals converge to govern phosphorylation of the Ume6p NTR. Our analysis further indicates that Mck1p and Rim11p both contribute to Ume6p NTR
phosphorylation under conditions of nitrogen limitation. The functional
significance of Ume6p NTR phosphorylation is supported by the synthetic
sporulation defect of the rim11-K68R mck1
double mutant
and by the sporulation defects caused by Ume6p substitutions that block
phosphorylation. Our results are consistent with a model in which
nitrogen limitation promotes Ume6p-Ime1p interaction
through increased Ume6p NTR phosphorylation (Fig.
4). Growth in the presence of nitrogen
results in low levels of Ume6p NTR phosphorylation, thus precluding
Ume6p-Ime1p interaction. Limitation for nitrogen causes elevated Ume6p
NTR phosphorylation, thus favoring Ume6p-Ime1p interaction, meiotic
gene expression, and sporulation.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Control of Ume6p NTR phosphorylation. Ume6p exists in
one of two states: without NTR phosphorylation or with NTR
phosphorylation. NTR phosphorylation is greatest in nitrogen-limited
cells and permits formation of an Ume6p-Ime1p complex and activation of
early meiotic genes. NTR phosphorylation may be carried out directly by
the GSK3 homologs Rim11p and Mck1p; Ime1p phosphorylation is carried
out only by Rim11p. NTR phosphorylation also depends on the protein
kinase Rim15p, a downstream target of the adenylate cyclase pathway.
|
|
Functional roles of Rim11p and Mck1p in meiosis.
The
possibility that Rim11p and Mck1p have overlapping functional roles was
first suggested by Puziss et al., who found that overexpression of
RIM11 can suppress a mitotic mck1 mutant defect (30). However, the lack of a synthetic rim11 mck1
growth defect suggested that overexpression may permit Rim11p to
substitute adventitiously for Mck1p. We have presented three
findings that argue that Rim11p and Mck1p naturally share a
function in nitrogen regulation of meiosis. First, rim11
mck1 double-null mutants are defective in accumulation of
phosphorylated GAD-Ume6p after nitrogen limitation. Second, Mck1p
interacts with the Ume6p NTR, as we found previously for Rim11p
(25). Third, sporulation of the partially defective
rim11-K68R mutant is abolished by an mck1
mutation. There is no novel sporulation defect of a rim11
mck1 double-null mutant because Rim11p is also required for
phosphorylation of Ime1p (4, 24, 32) (Fig. 4). Thus, our
results indicate that Rim11p and Mck1p have overlapping roles in
promoting Ume6p phosphorylation.
It is likely that the Ume6p NTR is phosphorylated directly by Rim11p
and Mck1p, based on three arguments. First, Rim11p immune
complexes
phosphorylate the Ume6p NTR in vitro (
25). Second,
both
Rim11p (
25) and Mck1p are capable of two-hybrid
interaction
with the Ume6p NTR. Third, Rim11p and Mck1p are both
GSK3 family
members, and Ume6p phosphorylation depends on GSK3
consensus site
residues. Our finding that the putative phosphoacceptor
residues
differ in functional importance (T99 > T103 > S107) fits with
the characterized GSK3 hierarchical
phosphorylation mechanism,
in which GSK3 prefers S-X-X-X-phosphoserine
to S-X-X-X-serine
as a substrate (
31). According to this
view, in Ume6p, phosphorylation
of S107 improves phosphorylation of
T103, and phosphorylation
of T103 improves phosphorylation of
T99. Therefore, a simple possibility
is that phosphorylation of only
T99 is critical for Ume6p to interact
with Ime1p, and
phosphorylation of T103 and S107 serves to accelerate
phosphorylation
of T99. The diminished interaction with Ime1p
of Ume6-T103Ap and
Ume6-S107Ap would then reflect the diminished
extent of T99
phosphorylation.
Rim11p and Mck1p have one shared function in meiosis, but each has
unique functions as well. This situation

redundancy for
one of several
functions in a single biological pathway

illustrates
a circumstance in
which protein kinase missense defects, rather
than complete deletions,
provide unique insight into functional
relationships between protein
kinases. Other situations include
adventitious substitution of one
protein kinase for another (
22)
and the action of two
protein kinases in a linear pathway (
12).
Rim11p and Mck1p
have a lower level of sequence identity (44%)
than many other pairs of
protein kinases with redundant functions
(Tpk1p/Tpk3p, 85%;
Cka1p/Cka2p, 61%; Tor1p/Tor2p, 70%; Pkh1p/Pkh2p,
65%; Mkk1p/Mkk2p,
59%), and Rim11p is more homologous to Mrk1p
than to Mck1p. It thus
seems likely that a systematic analysis
of other partially defective
protein kinase mutants for synthetic
defects may reveal new functional
relationships.
The function of the GSK3 homolog Mrk1p remains an enigma. Several
studies have failed to detect a
mrk1 phenotypic defect,
even
in backgrounds lacking other GSK3 homologs (
13,
14,
42).
Our results suggest that Mrk1p contributes to
phosphorylation
of full-length Ume6p, but its role in Ume6p NTR
phosphorylation
seems minor, as assessed by GAD-Ume6p mobility and by
sporulation
assays of
rim11-K68R MRK1 and
rim11-K68R mrk1 strains. We suggest
that Mrk1p may
phosphorylate Ume6p at sites outside the NTR and
cannot attribute
biological significance to the Mrk1p-Ume6p relationship
at this
time.
Relationship of Rim15p to Rim11p and Mck1p.
Our results argue
that Rim15p promotes Ume6p NTR phosphorylation and thus tie Rim15p,
Rim11p, and Mck1p to a single biochemical event. Rim15p is inhibited
through direct phosphorylation by cyclic AMP (cAMP)-dependent protein
kinase, and so our results provide a biochemical connection between the
cAMP and meiotic gene expression. However, cAMP levels respond to
glucose (40), yet here Rim15p is required for a nitrogen
starvation response. Thus, our findings explain one of several
mechanisms by which the cAMP pathway governs meiosis but do not explain
how nitrogen limitation governs Ume6p NTR phosphorylation.
If Rim11p and Mck1p phosphorylate the Ume6p NTR directly, then Rim15p
may affect phosphorylation through an effect on the
kinases or Ume6p
itself. In vitro assays argue that Rim15p does
not govern Rim11p
protein kinase activity (
41). A second possibility
is that
Rim15p may serve as a priming kinase (
31,
33) that
phosphorylates Ume6p S107, thus accelerating phosphorylation of
Ume6p T103 by Rim11p and Mck1p. This model predicts that
properties
of Ume6p-S107Ap in a wild-type strain should mimic
properties
of Ume6p in a
rim15
strain. However, we find
that the S107A substitution
impairs Ume6p-Rim11p interaction, whereas a
rim15
mutation does
not (Y. Xiao and A. P. Mitchell,
unpublished data). Also, we have
not detected two-hybrid interaction
between Rim15p and the Ume6p
NTR (Xiao and Mitchell, unpublished).
Therefore, we believe that
Rim15p acts indirectly, for example, through
inhibition of protein
phosphatase expression or
activity.
A newly defined nitrogen response module.
Nitrogen
limitation causes diverse responses in yeast, including
expression of nitrogen catabolic genes, changes in permease stability, down-regulation of translational machinery,
sporulation, and filamentation. Several individual responses are
governed by defined gene products (15, 23, 29), and the TOR
signaling cascade may serve as a global regulator of nitrogen
response pathways (7, 9, 34, 42). Our finding that Rim11p
and Mck1p promote functional, nitrogen-responsive phosphorylation of
Ume6p raises two questions. First, does a known nitrogen response
pathway govern the activities of Rim11p and Mck1p? And second, do
Rim11p and Mck1p govern any responses to nitrogen limitation in
addition to activation of meiotic genes? We have observed that
rim11 mck1 double mutants are defective in stationary-phase
survival (Xiao and Mitchell, unpublished), and so these kinases may
together play a role in starvation responses broader than previously
thought. Analysis of Rim11p and Mck1p may explain how physiological and differentiation responses are coupled.
 |
ACKNOWLEDGMENTS |
We are grateful to past and present members of this lab for many
helpful discussions and to Teresa Lamb for comments on the manuscript.
This work was supported by grant GM39531 from the NIH.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Columbia University, 701 West 168th St., New York, NY
10032. Phone: (212) 305-8251. Fax: (212) 305-1741. E-mail:
apm4{at}columbia.edu.
 |
REFERENCES |
| 1.
|
Baudin, A.,
O. Ozier-Kalogeropoulos,
A. Denouel,
F. Lacroute, and C. Cullin.
1993.
A simple and efficient method for direct gene deletion in Saccharomyces cerevisiae.
Nucleic Acids Res.
21:3329-3330[Free Full Text].
|
| 2.
|
Benni, M. L., and L. Neigeborn.
1997.
Identification of a new class of negative regulators affecting sporulation-specific gene expression in yeast.
Genetics
147:1351-1366[Abstract].
|
| 3.
|
Bowdish, K. S., and A. P. Mitchell.
1993.
Bipartite structure of an early meiotic upstream activation sequence from Saccharomyces cerevisiae.
Mol. Cell. Biol.
13:2172-2181[Abstract/Free Full Text].
|
| 4.
|
Bowdish, K. S.,
H. E. Yuan, and A. P. Mitchell.
1994.
Analysis of RIM11, a yeast protein kinase that phosphorylates the meiotic activator IME1.
Mol. Cell. Biol.
14:7909-7919[Abstract/Free Full Text].
|
| 5.
|
Bowdish, K. S.,
H. E. Yuan, and A. P. Mitchell.
1995.
Positive control of yeast meiotic genes by the negative regulator UME6.
Mol. Cell. Biol.
15:2955-2961[Abstract].
|
| 6.
|
Brazill, D. T.,
J. Thorner, and G. S. Martin.
1997.
Mck1, a member of the glycogen synthase kinase 3 family of protein kinases, is a negative regulator of pyruvate kinase in the yeast Saccharomyces cerevisiae.
J. Bacteriol.
179:4415-4418[Abstract/Free Full Text].
|
| 7.
|
Cardenas, M. E.,
N. S. Cutler,
M. C. Lorenz,
C. J. Di Como, and J. Heitman.
1999.
The TOR signaling cascade regulates gene expression in response to nutrients.
Genes Dev.
13:3271-3279[Abstract/Free Full Text].
|
| 8.
|
Chu, S.,
J. DeRisi,
M. Eisen,
J. Mulholland,
D. Botstein,
P. O. Brown, and I. Herskowitz.
1998.
The transcriptional program of sporulation in budding yeast.
Science
282:699-705[Abstract/Free Full Text].
|
| 9.
|
Di Como, C. J., and K. T. Arndt.
1996.
Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases.
Genes Dev.
10:1904-1916[Abstract/Free Full Text].
|
| 10.
|
Durfee, T.,
K. Becherer,
R. Chen,
S. H. Yeh,
Y. Yang,
A. E. Killburn,
W. H. Lee, and S. J. Elledge.
1993.
The retinoblastoma protein associates with protein the phosphatase type 1 catalytic subunit.
Genes Dev.
7:555-569[Abstract/Free Full Text].
|
| 11.
|
Erdeniz, N.,
U. H. Mortensen, and R. Rothstein.
1997.
Cloning-free PCR-based allele replacement methods.
Genome Res.
7:1174-1183[Abstract/Free Full Text].
|
| 12.
|
Espinoza, F. H.,
A. Farrell,
J. L. Nourse,
H. M. Chamberlin,
O. Gileadi, and D. O. Morgan.
1998.
Cak1 is required for Kin28 phosphorylation and activation in vivo.
Mol. Cell. Biol.
18:6365-6373[Abstract/Free Full Text].
|
| 13.
|
Hajji, K.,
J. Clotet, and J. Arino.
1999.
Disruption and phenotypic analysis of seven ORFs from the left arm of chromosome XV of Saccharomyces cerevisiae.
Yeast
15:435-441[CrossRef][Medline].
|
| 14.
|
Hardy, T. A.,
D. Wu, and P. J. Roach.
1995.
Novel Saccharomyces cerevisiae gene, MRK1, encoding a putative protein kinase with similarity to mammalian glycogen synthase kinase-3 and Drosophila Zeste-White3/Shaggy.
Biochem. Biophys. Res. Commun.
208:728-734[CrossRef][Medline].
|
| 15.
|
Huang, H. L., and M. C. Brandriss.
2000.
The regulator of the yeast proline utilization pathway is differentially phosphorylated in response to the quality of the nitrogen source.
Mol. Cell. Biol.
20:892-899[Abstract/Free Full Text].
|
| 16.
|
Jiang, W.,
M. Y. Lim,
H. J. Yoon,
J. Thorner,
G. S. Martin, and J. Carbon.
1995.
Overexpression of the yeast MCK1 protein kinase suppresses conditional mutations in centromere-binding protein genes CBF2 and CBF5.
Mol. Gen. Genet.
246:360-366[CrossRef][Medline].
|
| 17.
|
Kadosh, D., and K. Struhl.
1997.
Repression by Ume6 involves recruitment of a complex containing Sin3 corepressor and Rpd3 histone deacetylase to target promoters.
Cell
89:365-371[CrossRef][Medline].
|
| 18.
|
Kaiser, C.,
S. Michaelis, and A. Mitchell.
1994.
Methods in yeast genetics.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 19.
|
Kane, S., and R. Roth.
1974.
Carbohydrate metabolism during ascospore development in yeast.
J. Bacteriol.
118:8-14[Abstract/Free Full Text].
|
| 20.
|
Kupiec, M.,
B. Byers,
R. E. Exposito, and A. P. Mitchell.
1997.
Meiosis and sporulation in Saccharomyces cerevisiae, p. 889-1036.
In
J. R. Pringle, J. R. Broach, and E. W. Jones (ed.), The molecular and cellular biology of the yeast Saccharomyces: cell cycle and cell biology, vol. 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 21.
|
Lorenz, M. C.,
R. S. Muir,
E. Lim,
J. McElver,
S. C. Weber, and J. Heitman.
1995.
Gene disruption with PCR products in Saccharomyces cerevisiae.
Gene
158:113-117[CrossRef][Medline].
|
| 22.
|
Madhani, H. D.,
C. A. Styles, and G. R. Fink.
1997.
MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation.
Cell
91:673-684[CrossRef][Medline].
|
| 23.
|
Magasanik, B.
1992.
Regulation of nitrogen utilization, p. 283-317.
In
E. W. Jones, J. R. Pringle, and J. R. Broach (ed.), The molecular and cellular biology of the yeast Saccharomyces: gene expression, vol. 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 24.
|
Malathi, K.,
Y. Xiao, and A. P. Mitchell.
1999.
Catalytic roles of yeast GSK3beta/Shaggy homolog Rim11p in meiotic activation.
Genetics
153:1145-1152[Abstract/Free Full Text].
|
| 25.
|
Malathi, K.,
Y. Xiao, and A. P. Mitchell.
1997.
Interaction of yeast repressor-activator protein Ume6p with glycogen synthase kinase 3 homolog Rim11p.
Mol. Cell. Biol.
17:7230-7236[Abstract].
|
| 26.
|
Mitchell, A. P., and K. S. Bowdish.
1992.
Selection for early meiotic mutants in yeast.
Genetics
131:65-72[Abstract].
|
| 27.
|
Neigeborn, L., and A. P. Mitchell.
1991.
The yeast MCK1 gene encodes a protein kinase homolog that activates early meiotic gene expression.
Genes Dev.
5:533-548[Abstract/Free Full Text].
|
| 28.
|
Park, H. D.,
R. M. Luche, and T. G. Cooper.
1992.
The yeast UME6 gene product is required for transcriptional repression mediated by the CAR1 URS1 repressor binding site.
Nucleic Acids Res.
20:1909-1915[Abstract/Free Full Text].
|
| 29.
|
Park, H. D.,
S. Scott,
R. Rai,
R. Dorrington, and T. G. Cooper.
1999.
Synergistic operation of the CAR2 (ornithine transaminase) promoter elements in Saccharomyces cerevisiae.
J. Bacteriol.
181:7052-7064[Abstract/Free Full Text].
|
| 30.
|
Puziss, J. W.,
T. A. Hardy,
R. B. Johnson,
P. J. Roach, and P. Hieter.
1994.
MDS1, a dosage suppressor of an mck1 mutant, encodes a putative yeast homolog of glycogen synthase kinase 3.
Mol. Cell. Biol.
14:831-839[Abstract/Free Full Text].
|
| 31.
|
Roach, P. J.
1991.
Multisite and hierarchal protein phosphorylation.
J. Biol. Chem.
266:14139-14142[Abstract/Free Full Text].
|
| 32.
|
Rubin-Bejerano, I.,
S. Mandel,
K. Robzyk, and Y. Kassir.
1996.
Induction of meiosis in Saccharomyces cerevisiae depends on conversion of the transcriptional repressor Ume6 to a positive regulator by its regulated association with the transcriptional activator Ime1.
Mol. Cell. Biol.
16:2518-2526[Abstract].
|
| 33.
|
Rubinfeld, B.,
I. Albert,
E. Porfiri,
C. Fiol,
S. Munemitsu, and P. Polakis.
1996.
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.
Science
272:1023-1026[Abstract].
|
| 34.
|
Schmidt, A.,
T. Beck,
A. Koller,
J. Kunz, and M. N. Hall.
1998.
The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.
EMBO J.
17:6924-6931[CrossRef][Medline].
|
| 35.
|
Shero, J. H., and P. Hieter.
1991.
A suppressor of a centromere DNA mutation encodes a putative protein kinase (MCK1).
Genes Dev.
5:549-560[Abstract/Free Full Text].
|
| 36.
|
Sia, R. A., and A. P. Mitchell.
1995.
Stimulation of later functions of the yeast meiotic protein kinase Ime2p by the IDS2 gene product.
Mol. Cell. Biol.
15:5279-5287[Abstract].
|
| 37.
|
Smith, H. E.,
S. E. Driscoll,
R. A. Sia,
H. E. Yuan, and A. P. Mitchell.
1993.
Genetic evidence for transcriptional activation by the yeast IME1 gene product.
Genetics
133:775-784[Abstract].
|
| 38.
|
Smith, H. E.,
S. S. Su,
L. Neigeborn,
S. E. Driscoll, and A. P. Mitchell.
1990.
Role of IME1 expression in regulation of meiosis in Saccharomyces cerevisiae.
Mol. Cell. Biol.
10:6103-6113[Abstract/Free Full Text].
|
| 39.
|
Strich, R.,
R. T. Surosky,
C. Steber,
E. Dubois,
F. Messenguy, and R. E. Esposito.
1994.
UME6 is a key regulator of nitrogen repression and meiotic development.
Genes Dev.
8:796-810[Abstract/Free Full Text].
|
| 40.
|
Thevelein, J. M., and J. H. de Winde.
1999.
Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae.
Mol. Microbiol.
33:904-918[CrossRef][Medline].
|
| 41.
|
Vidan, S., and A. P. Mitchell.
1997.
Stimulation of yeast meiotic gene expression by the glucose-repressible protein kinase Rim15p.
Mol. Cell. Biol.
17:2688-2697[Abstract].
|
| 42.
|
Zheng, X. F., and S. L. Schreiber.
1997.
Target of rapamycin proteins and their kinase activities are required for meiosis.
Proc. Natl. Acad. Sci. USA
94:3070-3075[Abstract/Free Full Text].
|
Molecular and Cellular Biology, August 2000, p. 5447-5453, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Inai, T., Yukawa, M., Tsuchiya, E.
(2007). Interplay between Chromatin and trans-Acting Factors on the IME2 Promoter upon Induction of the Gene at the Onset of Meiosis. Mol. Cell. Biol.
27: 1254-1263
[Abstract]
[Full Text]
-
Purnapatre, K., Gray, M., Piccirillo, S., Honigberg, S. M.
(2005). Glucose Inhibits Meiotic DNA Replication through SCFGrr1p-Dependent Destruction of Ime2p Kinase. Mol. Cell. Biol.
25: 440-450
[Abstract]
[Full Text]
-
Rubin-Bejerano, I., Sagee, S., Friedman, O., Pnueli, L., Kassir, Y.
(2004). The In Vivo Activity of Ime1, the Key Transcriptional Activator of Meiosis-Specific Genes in Saccharomyces cerevisiae, Is Inhibited by the Cyclic AMP/Protein Kinase A Signal Pathway through the Glycogen Synthase Kinase 3-{beta} Homolog Rim11. Mol. Cell. Biol.
24: 6967-6979
[Abstract]
[Full Text]
-
Pnueli, L., Edry, I., Cohen, M., Kassir, Y.
(2004). Glucose and Nitrogen Regulate the Switch from Histone Deacetylation to Acetylation for Expression of Early Meiosis-Specific Genes in Budding Yeast. Mol. Cell. Biol.
24: 5197-5208
[Abstract]
[Full Text]
-
Colomina, N., Liu, Y., Aldea, M., Gari, E.
(2003). TOR Regulates the Subcellular Localization of Ime1, a Transcriptional Activator of Meiotic Development in Budding Yeast. Mol. Cell. Biol.
23: 7415-7424
[Abstract]
[Full Text]
-
Shimizu, M., Takahashi, K., Lamb, T. M., Shindo, H., Mitchell, A. P.
(2003). Yeast Ume6p repressor permits activator binding but restricts TBP binding at the HOP1 promoter. Nucleic Acids Res
31: 3033-3037
[Abstract]
[Full Text]
-
Honigberg, S. M., Purnapatre, K.
(2003). Signal pathway integration in the switch from the mitotic cell cycle to meiosis in yeast. J. Cell Sci.
116: 2137-2147
[Abstract]
[Full Text]
-
Guo, T. B., Chan, K. C., Hakovirta, H., Xiao, Y., Toppari, J., Mitchell, A. P., Salameh, W. A.
(2003). Evidence for a Role of Glycogen Synthase Kinase-3{beta} in Rodent Spermatogenesis. J Androl
24: 332-342
[Abstract]
[Full Text]
-
Mosley, A. L., Lakshmanan, J., Aryal, B. K., Ozcan, S.
(2003). Glucose-mediated Phosphorylation Converts the Transcription Factor Rgt1 from a Repressor to an Activator. J. Biol. Chem.
278: 10322-10327
[Abstract]
[Full Text]
-
Hirata, Y., Andoh, T., Asahara, T., Kikuchi, A.
(2003). Yeast Glycogen Synthase Kinase-3 Activates Msn2p-dependent Transcription of Stress Responsive Genes. Mol. Biol. Cell
14: 302-312
[Abstract]
[Full Text]
-
Williams, R. M., Primig, M., Washburn, B. K., Winzeler, E. A., Bellis, M., Sarrauste de Menthiere, C., Davis, R. W., Esposito, R. E.
(2002). The Ume6 regulon coordinates metabolic and meiotic gene expression in yeast. Proc. Natl. Acad. Sci. USA
99: 13431-13436
[Abstract]
[Full Text]
-
Pak, J., Segall, J.
(2002). Regulation of the Premiddle and Middle Phases of Expression of the NDT80 Gene during Sporulation of Saccharomyces cerevisiae. Mol. Cell. Biol.
22: 6417-6429
[Abstract]
[Full Text]
-
Schaber, M., Lindgren, A., Schindler, K., Bungard, D., Kaldis, P., Winter, E.
(2002). CAK1 Promotes Meiosis and Spore Formation in Saccharomyces cerevisiae in a CDC28-Independent Fashion. Mol. Cell. Biol.
22: 57-68
[Abstract]
[Full Text]
-
Washburn, B. K., Esposito, R. E.
(2001). Identification of the Sin3-Binding Site in Ume6 Defines a Two-Step Process for Conversion of Ume6 from a Transcriptional Repressor to an Activator in Yeast. Mol. Cell. Biol.
21: 2057-2069
[Abstract]
[Full Text]
-
Lamb, T. M., Mitchell, A. P.
(2001). Coupling of Saccharomyces cerevisiae Early Meiotic Gene Expression to DNA Replication Depends Upon RPD3 and SIN3. Genetics
157: 545-556
[Abstract]
[Full Text]